Home
About
Overview
Sharing Data
ORCID
Help
History (9)
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.
Electrophorus
Defining the Minimal Clinically Important Difference and Patient Acceptable Symptom State After Endoscopic Gluteus Medius or Minimus Repair With or Without Labral Treatment and Routine Capsular Closure at Minimum 5-Year Follow-up.
Recovery of pituitary function following treatment of an unruptured giant cavernous carotid aneurysm using Surpass flow-diverting stents.
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009 Jun 18; 113(25):6304-14.
View in:
PubMed
subject areas
Adult
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Cycle
Chemical and Drug Induced Liver Injury
Down-Regulation
Female
HIV Infections
HIV-1
Humans
Immunologic Memory
Interleukin-7
Interleukin-7 Receptor alpha Subunit
Lymphocyte Count
Male
Maximum Tolerated Dose
Middle Aged
Recombinant Proteins
T-Lymphocyte Subsets
T-Lymphocytes, Regulatory
Viral Load